Sherrie H. Kaplan

University of California, Irvine

Papers

3

Total Citations

84

H-Index

3

About

Sherrie H. Kaplan is a leading health services researcher whose work focuses on patient-reported outcomes, quality of care, and shared decision-making, particularly in prostate cancer treatment. Her landmark 2015 study, "The Comparative Harms of Open and Robotic Prostatectomy in Population Based Samples" (64 citations), provided critical, population-level evidence on the functional harms of robotic versus open surgery, challenging assumptions of robotic superiority and informing patient counseling. Dr. Kaplan also advanced the interpretation of the widely-used EPIC-26 questionnaire, clarifying how domain scores translate into tangible functional outcomes for patients. As a key contributor to the CEASAR study, she helped demonstrate that nationally endorsed quality measures for prostate cancer surgery are often disconnected from patient outcomes, advocating for more meaningful, outcome-driven standards. Her work has profoundly shaped how clinicians and researchers measure and communicate treatment consequences, directly improving patient-centered care. With a career dedicated to bridging rigorous measurement and real-world patient experience, Dr. Kaplan’s research remains essential for guiding treatment decisions and policy in urologic oncology.

Research Focus

Key Achievements

3
H-Index
3
Papers
84
Total Citations
28
Avg Citations/Paper
🏆 Most Cited Paper
The Comparative Harms of Open and Robotic Prostatectomy in Population Based Samples
64 citations · 2015
📈 Most Prolific Year: 2015 (1 Papers)
🤝 Key Collaborators: 28
🏛 Institutions: University of California, Irvine

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago